Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRoyal United Hospitals Bath NHS Foundation Trust

About this trial

The goal of this observational study is to assess the efficacy that the addition of novel markers cardiac function, particularly of right ventricular (RV) function in echocardiography, and ECG have in detecting pulmonary hypertension.

The main questions it aims to answer are:

Can novel markers in ECG and echocardiography suggest the presence of PH? Can existing screening guidelines be improved with the addition of these markers?

Eligibility criteria

Qualifiers

Patients 18+ who have undergone TTE, ECG and RHC as part of their clinical care

Disqualifiers

Patients <18 years old

Known or suspected congenital heart disease

Patient has opted-out of allowing their data to be used for research and planning (via the national data opt-out choice in England, or equivalent data protection scheme in Scotland)

Trial design

Treatments tested in this trial

  • Electrocardiogram
  • Transthoracic echocardiogram
  • Right heart catheter

Treatment groups

2,500 Participants
are divided into 1 treatment group

Sponsors and collaborators

Royal United Hospitals Bath NHS Foundation Trust

Lead sponsor

Sheffield Teaching Hospitals NHS Foundation Trust

Collaborator

Royal Free Hospital NHS Foundation Trust

Collaborator

Golden Jubilee National Hospital

Collaborator

Papworth Hospital NHS Foundation Trust

Collaborator

University of Bath

Collaborator